Julphar Q1 Profit 35 Million Dirhams

About this update from Gulf Pharmaceutical Industries

GULF PHARMACEUTICAL INDUSTRIES JULPHAR CO ADX:JULPHAR:JULPHAR Q1 ATTRIBUTABLE PROFIT 35 MILLION DIRHAMSJULPHAR Q1 NET SALES 273.4 MILLION DIRHAMSJULPHAR - WORKING ON DIVERSIFYING SUPPLY CHAINS WHILE CONTINUING TO MONITOR ENERGY PRICES AND THEIR IMPACT ON OUR ACTIVITIESJULPHAR -WILL CONTINUE TO ENHANCE ITS FOOTPRINT IN CORE THERAPEUTIC SEGMENTS, DELIVERING ROBUST PERFORMANCE ACROSS UAE, KSA, IRAQ, AND MOROССОJULPHAR -PLANS EXPANDING MARKET SHARE IN STRATEGIC MARKETSJULPHAR -PLANS INVESTMENT IN NEW PHARMA AND BIOTECH MANUFACTURING FACILITY IN SAUDI ARABIAJULPHAR -PLANS TO ACCELERATE IN-HOUSE RD EFFORTS AND FOSTERING STRATEGIC ALLIANCES TO ENHANCE PRODUCT PORTFOLIOJULPHAR -PLANS TO LAUNCH NEW PRODUCTS IN CORE THERAPEUTIC AREASJULPHAR -DURING PERIOD ENDED 31 MARCH 2026, INVESTED AN AMOUNT OF AED 8.2 MILLION IN CAPITAL EXPENDITURES

View stock analysis, news, and events for Gulf Pharmaceutical Industries